Alnylam Pharmaceuticals
ALNY
#430
Rank
$54.51 B
Marketcap
$412.63
Share price
2.02%
Change (1 day)
62.36%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company